[A nephrogenic adenoma during treatment with intravesical BCG].
Two patients who had undergone resection of a transitional cell bladder tumor presented with nephrogenic adenoma of the bladder during treatment with BCG. Nephrogenic adenoma presenting in the course of intravesical chemotherapy has been previously reported in 5 cases and can mimic tumor recurrence. Thus, we consider the present case to be of special interest.
Fariña
L A
LA
Servicio de Urología, IUNA, Fundación Puigvert, Barcelona, España.
Laguna
P
P
Palou Redorta
J
J
Algaba
F
F
Santaularia
J M
JM
Vicente
J
J
D000236:Adenoma / Q000139:chemically induced* / Q000473:pathology; D000283:Administration, Intravesical; D000368:Aged; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D002278:Carcinoma in Situ / Q000473:pathology / Q000601:surgery; D002295:Carcinoma, Transitional Cell / Q000473:pathology / Q000601:surgery; D006801:Humans; D007668:Kidney / Q000473:pathology*; D008297:Male; D008679:Metaplasia / Q000139:chemically induced / Q000473:pathology; D008875:Middle Aged; D011182:Postoperative Care / Q000009:adverse effects; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced* / Q000473:pathology
D001500:BCG Vaccine
Adenoma nefrogénico en el curso del tratamiento con BCG intravesical.